ArticleMolecular therapy. Nucleic acids2018

Supplemental Treatment for Huntington's Disease with miR-132 that Is Deficient in Huntington's Disease Brain.

Masashi Fukuoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.